BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 25277461)

  • 1. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
    J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents.
    Łakomska I; Śmiłowicz D; Jakubowski M; Sitkowski J; Wojtczak A
    Materials (Basel); 2020 Nov; 13(23):. PubMed ID: 33255252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.
    Łakomska I; Fandzloch M; Muzioł T; Sitkowski J; Wietrzyk J
    J Inorg Biochem; 2012 Oct; 115():100-5. PubMed ID: 22926029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines.
    Łakomska I; Szłyk E; Sitkowski J; Kozerski L; Wietrzyk J; Pełczyńska M; Nasulewicz A; Opolski A
    J Inorg Biochem; 2004 Jan; 98(1):167-72. PubMed ID: 14659646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo [1,5-a]pyrimidines: spectroscopical characterization and cytotoxic activity in vitro.
    Łakomska I; Fandzloch M; Popławska B; Sitkowski J
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jun; 91():126-9. PubMed ID: 22366623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP.
    Łakomska I; Kooijman H; Spek AL; Shen WZ; Reedijk J
    Dalton Trans; 2009 Dec; (48):10736-41. PubMed ID: 20023903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
    Štarha P; Trávníček Z; Pazderová L; Dvořák Z
    J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses, crystal structures and antioxidant study of Zn(II) complexes with morin-5'-sulfonic acid (MSA).
    Pieniążek E; Kalembkiewicz J; Dranka M; Woźnicka E
    J Inorg Biochem; 2014 Dec; 141():180-187. PubMed ID: 25277460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
    Zhou Z; Chen F; Xu G; Gou S
    Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.
    Fandzloch M; Augustyniak AW; Dobrzańska L; Jędrzejewski T; Sitkowski J; Wypij M; Golińska P
    J Inorg Biochem; 2020 Sep; 210():111072. PubMed ID: 32563102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
    Fandzloch M; Jaromin A; Zaremba-Czogalla M; Wojtczak A; Lewińska A; Sitkowski J; Wiśniewska J; Łakomska I; Gubernator J
    Dalton Trans; 2020 Jan; 49(4):1207-1219. PubMed ID: 31903475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-
    Jakubowski M; Łakomska I; Kaszuba A; Wojtczak A; Sitkowski J; Jarzęcki AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
    Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
    Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New heteronuclear gold(I)-platinum(II) complexes with cytotoxic properties: are two metals better than one?
    Wenzel M; Bigaeva E; Richard P; Le Gendre P; Picquet M; Casini A; Bodio E
    J Inorg Biochem; 2014 Dec; 141():10-16. PubMed ID: 25172993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
    Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
    Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.